XELIRI

DRUG4 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute, Harbin Medical University, National University Hospital, Singapore, Zhejiang Cancer Hospital

Conditions

AdenocarcinomaChemotherapyColon CancerColorectal NeoplasmsRadiationSolid TumorToripalimab

Phase 1

PRECISE CURATE.AI Pilot Clinical Trial

National University Hospital, SingaporeSolid Tumor

Start: 2020-08-20End: 2023-08-01Target: 20Updated: 2023-03-29

Phase 2

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

TerminatedNCT00127036

H. Lee Moffitt Cancer Center and Research InstituteAdenocarcinoma, Colon Cancer

Start: 2003-10-31End: 2010-12-31Updated: 2017-03-23

XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

Harbin Medical UniversityChemotherapy, Colorectal Neoplasms

Start: 2018-03-01End: 2020-06-01Target: 66Updated: 2018-05-01

Phase 3

A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status

Zhejiang Cancer HospitalRadiation, Toripalimab

Start: 2022-11-01End: 2025-12-31Target: 174Updated: 2022-12-30

Related Papers

Anus preservation in low rectal adenocarcinoma based on MMR/MSI status (APRAM): a study protocol for a randomised, controlled, open-label, multicentre phase III trial.

2024-01-104 citations

CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial)

European Heart Journal - Digital Health2023-10-2411 citations

PRECISE CURATE.AI: A prospective feasibility trial to dynamically modulate personalized chemotherapy dose with artificial intelligence.

Journal of Clinical Oncology2022-06-0123 citations

Abstract CT211: Personalized, rational, efficacy-driven chemotherapy dosing via an artificial intelligence system (PRECISE): A protocol for the PRECISE CURATE.AI pilot clinical trial

Cancer Research2021-07-01

Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

Frontiers in Digital Health2021-03-1235 citations